BeyondSpring (BYSI) Other Non Operating Income (2016 - 2026)
BeyondSpring (BYSI) posted Other Non Operating Income of $50000.0 for Q1 2026, down 23.08% sequentially from $65000.0 in Q4 2025, and up 72.41% YoY from $29000.0 in Q1 2025.
BeyondSpring (BYSI) Other Non Operating Income (2016 - 2026) Analysis & Trends
BeyondSpring has reported Other Non Operating Income for 9 years, with the latest figure at $50000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 72.41% year-over-year to $50000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $192000.0 (up 118.32% YoY) and the FY2025 annual result came in at $165000.0, up 114.5% from the prior year.
- Other Non Operating Income fell to $50000.0 in Q1 2026 per BYSI's latest filing, from $65000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $128000.0 in Q3 2024 and troughed at -$1.2 million in Q4 2024.
- A 3-year average of -$101888.9 and a median of $30000.0 in 2025 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 313.64% in 2025, down 76.56% in 2025.
- Over 3 years, Other Non Operating Income stood at -$1.2 million in 2024, then jumped by 105.49% to $65000.0 in 2025, then retreated by 23.08% to $50000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $50000.0, $65000.0, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BeyondSpring | 29.85 Mn | 29.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 47,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | -1.18 Mn |
| Sep 30, 2024 | 128,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2021 | 3.04 Mn |
| Sep 30, 2021 | 749,000.00 |
| Jun 30, 2021 | 75,000.00 |
| Mar 31, 2021 | -31,000.00 |
| Dec 31, 2020 | 4.54 Mn |
| Sep 30, 2020 | 174,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | -74,000.00 |
| Dec 31, 2019 | 3.55 Mn |
| Sep 30, 2019 | -131,000.00 |